Jilin Aodong Pharmaceutical Group Co Ltd000623
± MixedCapitalrelevance
Board renewal and appointments are routine governance changes; no material impact on operations or strategy.
Impact on stocks 1
Others
Jilin Aodong Pharmaceutical Group Co LtdJilin Aodong has completed the election for its twelfth board of directors. Li Xiulin was elected chairman, and Guo Shuqin was elected vice chairwoman, with a term running from July 17, 2026 to July 17, 2029. The company also appointed Guo Shuqin as general manager, Zhang Shuyuan as chief financial officer, Wang Zhenyu as board secretary, and Zhao Renhe as securities affairs representative, with terms matching the board. In the first quarter of 2026, Jilin Aodong achieved revenue of 514 million yuan and net profit attributable to the parent company of 866 million yuan.
Jilin Aodong Pharmaceutical Group Co LtdBoard renewal and appointments are routine governance changes; no material impact on operations or strategy.